Autonomix Medical, Inc. Common Stock

NasdaqCM AMIX

Autonomix Medical, Inc. Common Stock Price to Earnings Ratio (P/E) on January 14, 2025: -0.35

Autonomix Medical, Inc. Common Stock Price to Earnings Ratio (P/E) is -0.35 on January 14, 2025, a 68.57% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Autonomix Medical, Inc. Common Stock 52-week high Price to Earnings Ratio (P/E) is -0.06 on July 09, 2024, which is 81.61% above the current Price to Earnings Ratio (P/E).
  • Autonomix Medical, Inc. Common Stock 52-week low Price to Earnings Ratio (P/E) is -1.80 on October 31, 2024, which is -420.36% below the current Price to Earnings Ratio (P/E).
  • Autonomix Medical, Inc. Common Stock average Price to Earnings Ratio (P/E) for the last 52 weeks is -0.48.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
NasdaqCM: AMIX

Autonomix Medical, Inc. Common Stock

CEO Mr. Bradley Hauser
IPO Date Jan. 29, 2024
Location United States
Headquarters 21 Waterway Avenue
Employees 5
Sector Health Care
Industries
Medical Instruments Biotechnology Pharmaceuticals
Description

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

StockViz Staff

January 15, 2025

Any question? Send us an email